Apollo Therapeutics and Oxford University enter into drug discovery and development collaboration
The University of Oxford and Apollo Therapeutics, a portfolio biopharmaceutical company, announce the signing of a drug discovery and development collaboration to translate breakthroughs made by biomedical researchers at Oxford. The collaboration is driven by the quality of science and the flourishing innovation environment at Oxford that has led to a critical mass of early […]